The agriculture company said it will use the technology it has licensed for new applications in crop editing and for research to bring new foods to market.
The partners inked a licensing deal to market and distribute TGen's DeepChek-TB as a compact, portable, and affordable diagnostic model for physician use.
CRISPR technology has made its way around the world, but in the wake of the He Jiankui controversy, the industry is asking what recourse it has against misuse.
Epigenomics terminated its collaboration with China's BioChain for the licensing of the septin9 marker and exclusive Chinese distribution rights for Epi proColon.
The license contains a new method and bioinformatic tools that improve detection in next-generation sequencing to help researchers identify rare gene variants.
